
Does Ozempic Lower Blood Pressure and Cholesterol?
Ozempic lowers systolic blood pressure about 2-3 mmHg in type 2 diabetes and trims triglycerides, but barely changes LDL. Label data, heart rate, outcomes.
Written by Dr. Sheri Tomas. Updated November 12, 2026.
Yes, Ozempic can lower blood pressure a little, but only modestly, and it is not approved to treat high blood pressure or high cholesterol. Across 29 trials in people with type 2 diabetes, semaglutide, the active ingredient in Ozempic, lowered systolic blood pressure (the top number) by about 2.3 mmHg compared with placebo or other diabetes drugs, and it did not change diastolic pressure (the bottom number). Its effect on cholesterol is smaller still: in a type 2 diabetes trial, LDL ("bad") cholesterol barely moved, while triglycerides, a type of blood fat, fell by about 14%. One point matters for reading any article on this topic: the Ozempic prescribing label itself reports no blood pressure or cholesterol results. Most of the detailed numbers come from the label of Wegovy, which contains the same drug at a higher dose and was tested largely in people without diabetes. This guide keeps those two apart, explains why the numbers move, and covers what Ozempic does and does not do for heart risk as of November 2026.
Ozempic, Blood Pressure and Cholesterol: The Short Answer
- 1Blood pressure: semaglutide lowers the top number by about 2 to 3 mmHg in type 2 diabetes; the bottom number barely changes.
- 2Not a blood pressure drug: Ozempic has no approval for high blood pressure, cholesterol or weight.
- 3Cholesterol: LDL changes are close to zero in type 2 diabetes; triglycerides fall by roughly 14%.
- 4Label gap: the Ozempic label has no blood pressure or lipid data; the figures usually quoted come from the higher-dose Wegovy label.
- 5Heart rate: Ozempic raises resting heart rate by about 2 to 3 beats per minute.
- 6Heart outcomes: in people with type 2 diabetes and heart disease, Ozempic reduced major heart events in the SUSTAIN 6 trial.
Does Ozempic Lower Blood Pressure?
Yes, but by a small amount. The largest analysis in people with type 2 diabetes, a 2024 meta-analysis of 29 randomized trials with nearly 27,000 participants, found that semaglutide lowered systolic blood pressure by 2.31 mmHg compared with placebo or other glucose-lowering drugs. The change in diastolic pressure was 0.09 mmHg, which is statistically no different from zero. Injected semaglutide (the form in Ozempic) and oral semaglutide gave similar results, about 2.4 and 2.5 mmHg.
To put that in context, a drop of 2 to 3 mmHg is real but smaller than what a typical blood pressure medicine achieves. It is a helpful side benefit for many people taking Ozempic for diabetes, not a reason to take it for blood pressure. The FDA-approved uses of Ozempic are blood sugar control in adults with type 2 diabetes, reducing the risk of major heart events in adults with type 2 diabetes and heart disease, and reducing kidney and heart risks in adults with type 2 diabetes and chronic kidney disease. You can read more about those uses in Ozempic for diabetes.
Why Do Ozempic and Wegovy Numbers Get Mixed Up?
Ozempic and Wegovy both contain semaglutide, but they are different products. Ozempic is approved at weekly doses up to 2 mg for type 2 diabetes. Wegovy is approved at 2.4 mg weekly (and a 7.2 mg option) for weight management and heart risk reduction, mostly studied in people without diabetes. We checked the full Ozempic label: it reports no blood pressure or cholesterol values at all. The Wegovy label, by contrast, has a trial-by-trial table of both. That is why many articles quote Wegovy numbers under an Ozempic headline. In this guide, any figure from the Wegovy label is labelled as such. The two drugs are compared in more detail in Ozempic vs Wegovy.
How Much Does Semaglutide Lower Blood Pressure Without Diabetes?
More than in diabetes, at the higher Wegovy dose. A 2023 meta-analysis of six trials in 4,744 people without diabetes found systolic pressure fell by 4.83 mmHg and diastolic by 2.45 mmHg compared with placebo. In the Wegovy label, the 2.4 mg obesity trial (Study 2) showed a 5.1 mmHg systolic and 2.4 mmHg diastolic difference versus placebo, while the trial in people with type 2 diabetes and obesity (Study 3) showed a smaller 3.4 / 0.7 mmHg difference. In the SELECT heart trial, also with 2.4 mg in people without diabetes, systolic pressure fell by 3.8 mmHg versus 0.5 mmHg on placebo. These results apply to Wegovy's dose and population and should not be read as what Ozempic will do.
Blood pressure change with semaglutide versus placebo or comparators (mmHg)
Wu 2024 meta-analysis (29 trials)
Type 2 diabetes
Semaglutide, injected or oral, various doses
-2.31
+0.09 (not significant)
Wegovy label, Study 3
Type 2 diabetes with overweight or obesity
Wegovy 2.4 mg weekly
-3.4
-0.7
Kennedy 2023 meta-analysis (6 trials)
No diabetes
Semaglutide (6 trials)
-4.83
-2.45
Wegovy label, Study 2
Obesity, no diabetes
Wegovy 2.4 mg weekly
-5.1
-2.4
SELECT trial (raw change, not difference)
Heart disease, no diabetes
Wegovy 2.4 mg weekly
-3.8 vs -0.5 on placebo
Not reported in our sources
None of these rows comes from the Ozempic label, which reports no blood pressure data.
Why Does Ozempic Lower Blood Pressure?
Mostly through weight loss, as far as current evidence shows. A 2024 analysis that pooled individual patient data from three trials of semaglutide 2.4 mg found a systolic drop of 4.95 mmHg, and weight loss explained a substantial part of it. People on semaglutide in those trials also tended to need less blood pressure medicine than people on placebo. Other mechanisms, such as effects on blood vessels or salt handling by the kidneys, have been proposed, but they are not proven. How the drug works in general is explained in how Ozempic works. Because the effect is linked to weight, people who lose less weight may see less change, and blood pressure may drift back up if the drug is stopped and weight returns, as discussed in what happens when you stop taking Ozempic.
Does Ozempic Lower Cholesterol and LDL?
Not by much. Again, the Ozempic label has no lipid data, so the best label-based numbers come from Wegovy. In the Wegovy trial of people with type 2 diabetes (Study 3), LDL cholesterol was 0.4% higher than with placebo, essentially no change, and total cholesterol was 0.9% lower. In people without diabetes (Study 2), LDL fell by 3.8% relative to placebo, and HDL ("good") cholesterol rose by 3.8%. For comparison, statins are designed to lower LDL by much larger amounts. If your doctor has advised a statin, semaglutide is not a replacement for it.
Does Ozempic Lower Triglycerides?
Yes. Triglycerides are the most consistent lipid change with semaglutide. In the Wegovy label, triglycerides fell 13.9% relative to placebo in people with type 2 diabetes and 15.8% in people without diabetes; with intensive lifestyle support (Study 4) the difference was 17.0%. In absolute terms, triglycerides in Study 2 fell 21.9% on semaglutide versus 7.3% on placebo. Weight loss and better blood sugar control both tend to lower triglycerides, which may explain part of this.
Cholesterol and triglyceride change versus placebo, relative % (Wegovy label data, not Ozempic)
Study 3: type 2 diabetes, 2.4 mg
-0.9%
+0.4%
+2.7%
-13.9%
Study 2: obesity, no diabetes, 2.4 mg
-3.3%
-3.8%
+3.8%
-15.8%
Study 4: with intensive lifestyle, 2.4 mg
-5.8%
-7.1%
+1.5%
-17.0%
Can Ozempic Replace Blood Pressure Medicine or a Statin?
No. The changes are too small to replace dedicated treatment, and Ozempic is not approved for either condition. Do not stop or reduce a blood pressure medicine or statin on your own. That said, if you lose weight on Ozempic and your home readings fall, your doctor may decide to adjust your blood pressure medicines; in the pooled trial analysis above, people on semaglutide were more likely to need less blood pressure treatment. That is a decision for your prescriber, based on repeated readings.
Can Ozempic Cause Low Blood Pressure or a Faster Heart Rate?
Ozempic slightly raises heart rate. According to the label, the 0.5 mg and 1 mg doses increased resting heart rate by an average of 2 to 3 beats per minute, compared with a small drop on placebo. The higher-dose Wegovy label reports 1 to 4 beats per minute. Most people will not notice this, but tell your doctor if you feel a racing or pounding heartbeat at rest.
Low blood pressure is a less direct risk. The Ozempic label warns about acute kidney injury caused by fluid loss from nausea, vomiting or diarrhea. Dehydration can also make blood pressure fall, especially in people taking diuretics (water pills) or other blood pressure drugs. Some drug-reference sites mention dizziness on standing, but we did not find this listed in the Ozempic label. Drinking enough fluid during stomach side effects helps; see Ozempic diarrhea for practical tips.
Does Ozempic Lower Heart Attack and Stroke Risk?
In people with type 2 diabetes and existing heart or kidney disease, yes, according to outcome trials. In SUSTAIN 6 (3,297 people), major adverse cardiovascular events, a combined measure of heart-related death, non-fatal heart attack and non-fatal stroke, occurred in 6.6% on Ozempic versus 8.9% on placebo, a 26% relative reduction. Non-fatal stroke was lower, while the differences in non-fatal heart attack and heart-related death alone were not statistically clear. In FLOW (3,533 people with type 2 diabetes and kidney disease, Ozempic 1 mg), the kidney and heart composite occurred in 18.7% versus 23.2%, and heart-related death in 7.0% versus 9.6%.
These outcome results are more important than the small blood pressure and cholesterol changes, and they are probably not explained by those changes alone. More on this is in Ozempic and heart health.
How Soon Might You See Changes on a Home Cuff or Lipid Panel?
We could not find a verified timeline. The trials above measured blood pressure and lipids after many months, mostly 68 to 104 weeks for the Wegovy trials, so they do not show how fast changes appear. Since much of the effect follows weight loss, any change is likely to be gradual. How long Ozempic takes to work on blood sugar and weight is covered in how long it takes for Ozempic to work.
When to Talk to Your Doctor
- 1Your home readings are consistently lower than usual, or you feel dizzy or lightheaded, especially if you take blood pressure medicine
- 2You have vomiting or diarrhea and cannot keep fluids down, since dehydration can affect blood pressure and the kidneys
- 3You notice a fast or pounding heartbeat at rest
- 4You are thinking about stopping a statin or blood pressure medicine
- 5You have kidney disease and are starting or increasing Ozempic
What to Do Next: Questions to Ask Your Doctor
- 1Should I check my blood pressure at home, and how often?
- 2At what readings would you consider lowering my blood pressure medicine?
- 3When should I repeat my cholesterol and triglyceride tests?
- 4Is my statin dose still right for my heart risk?
- 5Should I hold a diuretic if I have stomach side effects?
- 6Do my kidney tests need checking more often?
General safety questions are covered in is Ozempic safe, and weight-related effects in Ozempic for weight loss.
The Bottom Line
Ozempic lowers systolic blood pressure by about 2 to 3 mmHg in people with type 2 diabetes and lowers triglycerides, but it hardly changes LDL cholesterol and it is not a treatment for high blood pressure or high cholesterol. The bigger numbers often quoted come from Wegovy's higher dose in people without diabetes, not from Ozempic. Its proven heart benefit in diabetes comes from outcome trials, not from these risk-factor changes. Keep taking your blood pressure medicine and statin unless your doctor changes them.
FAQ
We found no verified timeline. Trials measured blood pressure after many months, and much of the effect follows weight loss, so any drop is likely to be gradual.
Not on your own. Ozempic lowers blood pressure only slightly. If your readings fall as you lose weight, your doctor may adjust your medicine.
Barely. In a Wegovy trial in type 2 diabetes, LDL was essentially unchanged versus placebo. The Ozempic label reports no cholesterol data. It does not replace a statin.
Yes, modestly. In Wegovy label trials, triglycerides fell about 14% to 17% relative to placebo. The Ozempic label has no lipid data.
Not directly in the label, but dehydration from vomiting or diarrhea can lower blood pressure, especially with water pills. Tell your doctor if you feel dizzy.
Yes, slightly. The label reports an average increase of 2 to 3 beats per minute at the 0.5 mg and 1 mg doses.
Sources
- 1Novo Nordisk. Ozempic (semaglutide) injection prescribing information, revised 05/2026, U.S. Food and Drug Administration, 2026
- 2Novo Nordisk. Wegovy (semaglutide) injection and tablets prescribing information, revised 05/2026, U.S. Food and Drug Administration, 2026
- 3Wu W et al. The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis, Endocrine, 2024
- 4Kennedy C et al. The effect of semaglutide on blood pressure in patients without diabetes: a systematic review and meta-analysis, Journal of Clinical Medicine, 2023
- 5Kennedy C et al. Semaglutide and blood pressure: an individual patient data meta-analysis, European Heart Journal, 2024
- 6American College of Cardiology. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity - SELECT, ACC, 2023
This article summarizes published research and FDA labeling for general information and is not medical advice. The SUSTAIN 6, FLOW, SELECT and Wegovy trials were funded by Novo Nordisk, the maker of Ozempic and Wegovy.

Dr. Sheri Tomas
Author
Comments (0)
Be the first to comment on this article.




